Skip to Content
Merck
CN
  • Perilla oil and exercise decrease expressions of tumor necrosis factor-alpha, plasminogen activator inhibitor-1 and highly sensitive C-reactive protein in patients with hyperlipidemia.

Perilla oil and exercise decrease expressions of tumor necrosis factor-alpha, plasminogen activator inhibitor-1 and highly sensitive C-reactive protein in patients with hyperlipidemia.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan (2013-06-26)
Minggang Wei, Peihua Xiong, Ling Zhang, Mei Fei, Aiping Chen, Fengling Li
ABSTRACT

To verify the effects of perilla oil on the regulation of blood lipid levels in patients with hyperlipidemia. Blood was taken from patients prior to and 8 weeks following treatment with perilla oil. Different ways to test for indexes which correlate to hyperlipidemia were performed. Some indexes, which correlate with inflammation and injury to endothelial cells, were tested using enzyme linked immunosorbent assays. Serum lipid levels [triglyceride (TG), total cholesterol (TC), and low-density lipoprotein-cholesterol (LDL-C)] changed significantly after 56 days of treatment. Differences were noted as early as 28 days after treatment began (P < 0.05). Treatment with perilla oil showed statistically significant recovery levels of high-density lipoprotein-cholesterol (HDL-C) after 28 and 56 days of treatment. Plasma lipids levels were significantly lower after 56 days of treatment (P < 0.05). Perilla oil reduced blood lipid levels in patients, and the regulation of cell signaling factor levels had no adverse effects on patients' liver or kidney function, or blood routine examinations. Perilla oil treatment is safe in clinical use, can regulate blood lipid levels and protects the function of endothelial cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
C Reactive Protein from human fluids, buffered aqueous solution
Sigma-Aldrich
Linolenic acid, ≥99%
Sigma-Aldrich
Linolenic acid, ~70% (GC)
Supelco
Linolenic acid, analytical standard